CONTACT: Catherine LondonAssociate Director, Communications and Public RelationsBoehringer Ingelheim Pharmaceuticals, Inc.Email: email@example.comPhone: (203) 798-4638Tammy HullCommunications ManagerLilly DiabetesEmail: firstname.lastname@example.orgPhone: (317) 651-9116
Boehringer Ingelheim And Eli Lilly And Company Announce Positive Top-line Pivotal Phase III Data Results For Empagliflozin
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.